Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TP53 Mutations in Acute Leukemias and Myelodysplastic Syndromes: Insights and Treatment Updates
Valeria Santini, Maximilian Stahl, David A. Sallman
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 14

Showing 14 citing articles:

Comprehensive Characterization of Overt Myelofibrosis in an Asian Cohort: Phenotype, Mutation Landscape and Discordance Among Scoring Systems
Yin-Yin Chang, Yu‐Hung Wang, Chao‐Hung Wei, et al.
Hematological Oncology (2025) Vol. 43, Iss. 1
Closed Access
Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances
Nishanth Thalambedu, Bhavesh Mohan Lal, Brent K. Harbaugh, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 508-508
Open Access
Features of TP53-mutated patients with chronic myelomonocytic leukemia in a national (ABCMML) and international cohort (cBIOPORTAL)
M Grass, Klaus Geißler
Wiener Medizinische Wochenschrift (2025)
Open Access
TP53‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management
Mithun Vinod Shah, Daniel A. Arber, Devendra Hiwase
American Journal of Hematology (2025)
Open Access
Multihit TP53 Mutations in Myeloproliferative Neoplasms and Acute Myeloid Leukemia: Comparative Analysis of Survival and Risk Factors in 142 Informative Cases
Saubia Fathima, Maymona Abdelmagid, Ali Alsugair, et al.
American Journal of Hematology (2025)
Closed Access
What is radiation-induced acute myeloid leukaemia/can it be accurately identified?
Christophe Badie, Robert Peter Gale
Leukemia (2025)
Open Access
Targeted therapies for myelodysplastic Syndromes/Neoplasms (MDS): current landscape and future directions
Aram Bidikian, Jan Philipp Bewersdorf, Rory M. Shallis, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 11, pp. 1131-1146
Closed Access | Times Cited: 1
Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies
Pasquale Niscola, Valentina Gianfelici, Gianfranco Catalano, et al.
Current Oncology (2024) Vol. 31, Iss. 11, pp. 6632-6658
Open Access | Times Cited: 1
A Line in Shifting Sand: Can We Define and Target TP53 Mutated MDS?
Sarah Skuli, Andrew Matthews, Martin Carroll, et al.
Seminars in Hematology (2024)
Closed Access | Times Cited: 1
Identify truly high-risk TP53-mutated diffuse large B cell lymphoma patients and explore the underlying biological mechanisms
Kai‐Xin Du, Yifan Wu, Hua Wei, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
Introduction to Neoplasia
Prokopios P. Argyris, Mark C. Herzberg
Elsevier eBooks (2024)
Closed Access
Epidemiological and genetic insights into the co-occurrence of cutaneous melanoma and hematologic malignancies: a meta-analytic review
Amit Kumar, Arunan Jeyakumar, Alfred K. Lam, et al.
Leukemia Research (2024) Vol. 147, pp. 107610-107610
Open Access
Pediatric therapy-related hematologic neoplasms show enrichment for KMT2A rearrangement and lymphoblastic phenotype
Alexandra E. Kovach, Daria Komova, Albert Itov, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 12, pp. 1840-1852
Closed Access
Diagnostics and Therapy for Malignant Tumors
Chih‐Yang Tsai, Chunyu Wang, Hasok Chang, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2659-2659
Open Access
Page 1

Scroll to top